Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 163 Lung Neoplasms 53 Neoplasms 14 Neoplasm Metastasis 10 NSCLC 10 Brain Neoplasms 10 Carcinoma 9 Meningeal Carcinomatosis 6 Colorectal Neoplasms 5 Bronchial Neoplasms 5 Thoracic Neoplasms 4 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Neoplasms by Site 3 Lung Diseases 3 Carcinoma, Squamous Cell 3 Breast Neoplasms 3 Adenocarcinoma of Lung 3 Adenocarcinoma 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Prostatic Neoplasms 2 Noonan Syndrome 2 Non Small Cell Lung Cancer Metastatic 2

Interventions

pembrolizumab 1 osimertinib 1 binimetinib 1 Pemetrexed 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Non-small Cell Carcinoma × osimertinib × Clear all

NCT04695925 2025-10-15

TOP

Sun Yat-sen University

Phase 3 Active not recruiting

Non-small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡